BRN

0.00%

23.0¢ brainchip holdings ltd

"The really good news is that NOBODY has reported that Akida is...

First 7335 Last

Share
Profile

Follow
Stickshift

7,901 Posts.

2080

26/07/24

13:58

Post #: 74932776
Share

Originally posted by MarketingMan: ↑

A rental property would give you consistent and reliable income - and tenants to manage (have you ever done that? It's a pain in the arse).
But, won't give you the kind of explosive growth that BRN might achieve. I said MIGHT.

The old investment formulae was one third each in property, equities, and cash. Stick to Blue-Chip stocks.
Such a strategy will see you comfortably into your cardigan years dying of boredom.

For a more exciting life with the very real prospect of heart stopping moments we have Brainchip.

I believe the blame for the slow progress (some say "no progress") achieved to date is not with Brainchip but with its potential clients.
They are taking a very long time to evaluate and develop applications. Some here on this forum say the board and management should be doing more.
More what? Harder sales pitch? Shout louder? Ring more people? More strippers and lap-dancers? Pay bribes?

The real issue is the lack of engineers who understand AI let alone neuromorphic AI.

And it's no good just getting up-to-speed (buying an evaluation board, making it run, writing some Python code and downloading some AI scripts from the BRN Zoo). To really develop something robust and useful you need to develop competence. That takes time. As we are finding out - years.

I believe this is all happening. Fact Finder and others have littered this forum with ample evidence many are playing with BRN technology.
Up-skilling is a happening thing.

The really good news is that NOBODY has reported that Akida is under-cooked or doesn't do what it promises - NOBODY.

And we can't deny that AI will feature prominently in our futures. Some say too prominently. It's coming.

Took the inventor of Xerox technology 17 years to get the first XEROX printer commercialized. That technology has been a great success (still used in LAZER printers and lithographic plate making today) and has been printing money for the last 75 years.

Sorry guys this is just a waiting game (I don't think 17 years - it took the inventor of xerography 7 years just to find an investor).

Want more certainty and modest returns - Blue Chip and property
Want uncertainty and possibly HUGE returns - bleeding edge technology.

Take your pick.

Expand

"The really good news is that NOBODY has reported that Akida is under-cooked or doesn't do what it promises - NOBODY"

BRN literally told the market that Akida 1.0 didn't meet some of the commercial needs of clients, hence the hurried revisions to commercialise 2.0.

Akida 1.0 was a commercial failure IMO. It's little wonder that two 1.0 chips were included in the edge box, a convenient way to get rid of unwanted stock.

Last edited by Stickshift: 26/07/24

BRN Price at posting: 19.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 2,660 more messages in this thread...

First 7335 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $451.3M

Open	High	Low	Value	Volume
23.0¢	24.0¢	21.5¢	$2.863M	12.69M

Buyers (Bids)

No.	Vol.	Price($)
6	136498	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	444756	13

View Market Depth

No.	Vol.	Price($)
4	86498	0.230
3	155000	0.225
16	439886	0.220
14	751341	0.215
35	871743	0.210

Price($)	Vol.	No.
0.235	360988	11
0.240	791244	17
0.245	612347	15
0.250	151787	5
0.255	132485	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

BRN (ASX) Chart

"The really good news is that NOBODY has reported that Akida is...

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"The really good news is that NOBODY has reported that Akida is...

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News